Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function.

[1]  S. Waikar,et al.  Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. , 2010, Kidney international.

[2]  H. Tighiouart,et al.  CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study , 2009, BMC nephrology.

[3]  T. Sugaya,et al.  Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. , 2009, American journal of physiology. Renal physiology.

[4]  J. Thurman,et al.  Peeking into the black box: new biomarkers for acute kidney injury. , 2008, Kidney international.

[5]  H. Taniguchi,et al.  Renal L-type fatty acid--binding protein in acute ischemic injury. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  T. Sugaya,et al.  Urinary fatty acid binding protein in renal disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[7]  Tadashi Yamamoto,et al.  Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules , 2005, Laboratory Investigation.

[8]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[9]  T. Nakata,et al.  Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic and Prognostic Marker in Acute Coronary Syndrome , 2003, Cardiology.

[10]  T. Nakamura,et al.  Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis. , 2006, Clinical nephrology.

[11]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .